Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

SCLX | Scilex Holding Company

Index- P/E- EPS (ttm)-0.63 Insider Own2.20% Shs Outstand149.06M Perf Week-15.38%
Market Cap196.76M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float145.78M Perf Month-57.42%
Income-81.52M PEG- EPS next Q- Inst Own14.26% Short Float / Ratio1.89% / 4.15 Perf Quarter-76.76%
Sales23.16M P/S8.50 EPS this Y- Inst Trans-9.62% Short Interest2.75M Perf Half Y-83.80%
Book/sh0.07 P/B18.85 EPS next Y- ROA-60.66% Target Price- Perf Year-87.23%
Cash/sh0.23 P/C5.77 EPS next 5Y- ROE-163.31% 52W Range1.28 - 16.90 Perf YTD-66.92%
Dividend- P/FCF- EPS past 5Y- ROI-626.55% 52W High-92.19% Beta0.82
Dividend %- Quick Ratio0.64 Sales past 5Y10.72% Gross Margin67.14% 52W Low3.13% ATR0.26
Employees90 Current Ratio0.67 Sales Q/Q- Oper. Margin-481.04% RSI (14)20.85 Volatility12.12% 12.24%
OptionableYes Debt/Eq3.62 EPS Q/Q- Profit Margin-351.93% Rel Volume0.76 Prev Close1.33
ShortableYes LT Debt/Eq0.25 Earnings- Payout- Avg Volume662.02K Price1.32
Recom- SMA20-35.23% SMA50-60.43% SMA200-79.19% Volume52,037 Change-0.75%
Today 09:00AM
Sep-27-23 09:00AM
Sep-25-23 09:00AM
Sep-22-23 11:38AM
Sep-21-23 04:05PM
09:00AM Loading…
Sep-14-23 09:00AM
Sep-13-23 09:00AM
Sep-12-23 05:34PM
Sep-11-23 09:00AM
Jul-27-23 09:00AM
Jul-21-23 05:53PM
Jul-20-23 09:00AM
Jul-13-23 09:00AM
09:00AM Loading…
Jul-05-23 09:00AM
Jun-16-23 09:00AM
Jun-15-23 09:03AM
Jun-01-23 12:28PM
May-31-23 03:16PM
May-22-23 09:00AM
May-14-23 03:00PM
May-05-23 06:08AM
May-04-23 09:00AM
Apr-28-23 02:42PM
Apr-27-23 07:26AM
Apr-25-23 07:30PM
09:00AM Loading…
Apr-17-23 09:00AM
Apr-14-23 06:32PM
Apr-13-23 12:25PM
Apr-05-23 05:27PM
Apr-04-23 01:49PM
Mar-27-23 09:00AM
Mar-21-23 09:00AM
Mar-08-23 10:13AM
Feb-27-23 09:00AM
Feb-18-23 08:37PM
Feb-17-23 03:47PM
Feb-16-23 02:40PM
Feb-13-23 03:46PM
Feb-04-23 10:48PM
Feb-03-23 08:59PM
Feb-02-23 01:15PM
Jan-20-23 10:24AM
Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTlido, a prescription lidocaine topical product approved by the FDA for the relief of neuropathic pain associated with PHN, which is a form of post-shingles nerve pain, and e GLOPERBA oral solutions, an FDA-approved prophylactic treatment for painful gout flares in adults. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.